Baxter Informs A.S.P.E.N. that Intralipid Removed from Allocation

Baxter has informed A.S.P.E.N. that supplies of Intralipid have improved and they have removed it from allocation although purchases will continue to be made directly through the company. For more information, see the Letter to the Customer.